MedTrace Logo

Effectiveness of Human Rotavirus Vaccine, Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants

NCT00655187 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1270

Last updated 2017-05-30

No results posted yet for this study

Summary

This study aims to evaluate the effectiveness of Rotarix™ vaccine in the general population in Singapore by monitoring the overall reduction in RV SGE and also by assessing the direct protection offered by the vaccine in hospitalised infants through a case-control study.

Conditions

  • Rotavirus Severe Gastroenteritis

Interventions

OTHER

Collection of information

Information regarding demographic characteristics, medical history, previous participation in rotavirus clinical trials and vaccination history will be collected.

PROCEDURE

Collection of stool samples

Stools samples will be collected during hospitalisation for RV testing and genotyping of RV positive samples.

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2010-07-31
Completion
2010-07-31

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00655187 on ClinicalTrials.gov